Ruo Chen

2.4k total citations · 1 hit paper
37 papers, 651 citations indexed

About

Ruo Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Ruo Chen has authored 37 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Immunology. Recurrent topics in Ruo Chen's work include Signaling Pathways in Disease (8 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Ruo Chen is often cited by papers focused on Signaling Pathways in Disease (8 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Ruo Chen collaborates with scholars based in China, United States and Netherlands. Ruo Chen's co-authors include Zhi‐Nan Chen, Jiejie Geng, Jiao Wu, Zhuan Feng, Huijie Bian, Wenjun Mao, Gang Nan, Mingfeng Zheng, Guanyu Jiang and Ping Zhu and has published in prestigious journals such as Nature Communications, Blood and Analytical Chemistry.

In The Last Decade

Ruo Chen

33 papers receiving 648 citations

Hit Papers

TNF antagonist sensitizes synovial fibroblasts to ferropt... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruo Chen China 13 371 213 207 157 132 37 651
Gang Nan China 16 432 1.2× 144 0.7× 180 0.9× 182 1.2× 148 1.1× 26 753
Shan Huang China 15 390 1.1× 97 0.5× 140 0.7× 208 1.3× 103 0.8× 40 705
Xumin Zhou China 14 403 1.1× 186 0.9× 286 1.4× 62 0.4× 105 0.8× 22 627
Pengbo Deng China 15 334 0.9× 214 1.0× 228 1.1× 153 1.0× 210 1.6× 39 712
Shuyu Fu China 10 314 0.8× 93 0.4× 210 1.0× 309 2.0× 163 1.2× 18 732
Meng Hong China 11 285 0.8× 62 0.3× 214 1.0× 186 1.2× 188 1.4× 28 609
Fangyin Zeng China 11 295 0.8× 151 0.7× 170 0.8× 92 0.6× 133 1.0× 25 544
Shen‐Wu Wang China 11 274 0.7× 113 0.5× 89 0.4× 179 1.1× 124 0.9× 20 638
Yuki Katayama Japan 12 226 0.6× 218 1.0× 120 0.6× 81 0.5× 369 2.8× 30 619

Countries citing papers authored by Ruo Chen

Since Specialization
Citations

This map shows the geographic impact of Ruo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruo Chen more than expected).

Fields of papers citing papers by Ruo Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruo Chen. The network helps show where Ruo Chen may publish in the future.

Co-authorship network of co-authors of Ruo Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ruo Chen. A scholar is included among the top collaborators of Ruo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruo Chen. Ruo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Wei, Jiwei Liu, Ruo Chen, et al.. (2025). Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. Chinese Journal of Cancer Research. 37(5). 796–820.
3.
Chen, Ruo, Haowei Zhang, Peijuan Liu, et al.. (2024). Dclre1c-Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research. Biomolecules. 14(2). 180–180. 1 indexed citations
4.
Chen, Xiaohong, Lin Peng, Jiao Wu, et al.. (2024). CD147‐K148me2‐Driven Tumor Cell‐Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis. Advanced Science. 11(29). e2400611–e2400611. 10 indexed citations
5.
Zhao, He, Ruixin Wang, Jiwei Liu, et al.. (2024). Exploring the causal relationship between immune cells and idiopathic pulmonary fibrosis: a bi-directional Mendelian randomization study. BMC Pulmonary Medicine. 24(1). 145–145. 4 indexed citations
6.
Chen, Ruo, Jiaxin Li, Yumeng Zhu, et al.. (2024). Fragile Treg cells: Traitors in immune homeostasis?. Pharmacological Research. 206. 107297–107297. 11 indexed citations
7.
Wang, Yarong, Ying Shi, Xiaohong Chen, et al.. (2023). SETDB1-mediated CD147-K71 di-methylation promotes cell apoptosis in non-small cell lung cancer. Genes & Diseases. 11(2). 978–992. 12 indexed citations
8.
Jiang, Guanyu, et al.. (2023). Recurrent lung adenocarcinoma benefits from microwave ablation following multidisciplinary treatments: A case with long-term survival. Frontiers in Surgery. 9. 1038219–1038219. 1 indexed citations
9.
Jiang, Guanyu, He Zhao, Ruixin Wang, et al.. (2023). Identification and validation of a novel NK cells-related signature to predict prognosis and immune microenvironment in LUAD. Immunobiology. 228(6). 152751–152751.
10.
Wang, Xiaokun, Yongrui Xu, Jinyu Xu, et al.. (2023). Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis. Translational Cancer Research. 12(4). 804–827. 1 indexed citations
11.
Mei, Jie, Guanyu Jiang, Yundi Chen, et al.. (2022). HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC. BMC Cancer. 22(1). 738–738. 17 indexed citations
12.
Wu, Jiao, Zhuan Feng, Liang Chen, et al.. (2022). TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models. Nature Communications. 13(1). 676–676. 190 indexed citations breakdown →
13.
Mao, Wenjun, Yun Cai, Danrong Chen, et al.. (2022). Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer. JCI Insight. 7(18). 100 indexed citations
14.
Wang, Ke, Wan Huang, Ruo Chen, et al.. (2021). Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export. Cell Metabolism. 33(1). 160–173.e6. 45 indexed citations
15.
Geng, Jiejie, Ruo Chen, Lin Peng, et al.. (2021). CD98-induced CD147 signaling stabilizes the Foxp3 protein to maintain tissue homeostasis. Cellular and Molecular Immunology. 18(12). 2618–2631. 14 indexed citations
16.
Mao, Wenjun, et al.. (2021). Germline mutation analyses of malignant ground glass opacity nodules in non-smoking lung adenocarcinoma patients. PeerJ. 9. e12048–e12048. 1 indexed citations
17.
Chen, Ruo, Ke Wang, Zhuan Feng, et al.. (2020). CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ. Cellular and Molecular Immunology. 18(1). 171–181. 18 indexed citations
18.
Chen, Ruo, Shijie Wang, Yang Zhang, et al.. (2016). CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinoma. Cancer Cell International. 16(1). 69–69. 7 indexed citations
19.
Chen, Ruo, et al.. (2008). Montmorillonite Powder vs.Racecadotril Granule for Acute Infantile Diarrhea:Cost-minimization Analysis. Zhongguo yaofang. 1 indexed citations
20.
Chen, Jingyu, et al.. (2005). [The operative technique selection of lung transplantation for end-stage emphysema].. PubMed. 43(22). 1444–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026